Rhenman & Partners Asset Management AB

Position in JNJ — Johnson & Johnson

CIK 1599882 Stockholm, V7

Position in JNJ

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$18,412,825

+$747,825 QoQ

Shares Held

72,500

-27.5% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

1.74%

of 13F equity value

Holder Rank

#781

of 4,676 holders

Holding Since

Dec 2020

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Rhenman & Partners Asset Management AB holds $173,015,372 across 8 Drug Manufacturers - General names. JNJ ranks #7 (10.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AZN	Astrazeneca PLC	151,500	$28,727,430
2	MRK	Merck & Co., Inc.	213,500	$27,434,750
3	LLY	ELI LILLY & Co	22,315	$26,765,282
4	ABBV	AbbVie Inc.	96,775	$24,352,461
5	GILD	Gilead Sciences, Inc.	178,250	$22,520,105
6	BIIB	Biogen Inc.	94,850	$20,493,291
7	JNJ	Johnson & Johnson This page	72,500	$18,412,825
8	AMGN	Amgen Inc	11,900	$4,309,228

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$18,412,825	72,500	-27.5%	Shares	Sole	2026-08-13
2022-12-31	$17,665,000	100,000	0.0%	Shares	Sole	2023-02-13
2022-09-30	$16,336,000	100,000	0.0%	Shares	Sole	2022-11-14
2022-06-30	$17,751,000	100,000	-11.5%	Shares	Sole	2022-08-12
2022-03-31	$20,026,990	113,000	-55.3%	Shares	Sole	2022-05-13
2021-12-31	$43,280,710	253,000	-6.3%	Shares	Sole	2022-02-11
2021-09-30	$43,605,000	270,000	+260.0%	Shares	Sole	2021-11-12
2021-06-30	$12,355,500	75,000	-76.9%	Shares	Sole	2021-08-13
2021-03-31	$53,413,750	325,000	+182.6%	Shares	Sole	2021-05-14
2020-12-31	$18,098,700	115,000	—	Shares	Sole	2021-01-19
No filing history on record for this holder in this stock.